China has approved for human trial, the first nasal spray vaccine against the coronavirus that has claimed over 904,000 lives globally. The nasal spray vaccine is expected to start phase 1 clinical trials in November.
According to Global Times, it is the only vaccine of its type that has gained approval by the China’s National Medical Products Administration.
A Beijing-based Immunologist revealed that compared with injections, a nasal spray vaccine is easier to administer and would also be easy to mass-produce, and distribute as it adopts the mature influenza vaccine production technology.
Categories: Stories Around the Globe